SFOSF
Price
$2.85
Change
+$0.01 (+0.35%)
Updated
Sep 4 closing price
Capitalization
10.66B
TCNNF
Price
$7.58
Change
+$0.33 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.46B
58 days until earnings call
Interact to see
Advertisement

SFOSF vs TCNNF

Header iconSFOSF vs TCNNF Comparison
Open Charts SFOSF vs TCNNFBanner chart's image
Shanghai Fosun Pharmaceutical Group
Price$2.85
Change+$0.01 (+0.35%)
Volume$120
Capitalization10.66B
Trulieve Cannabis
Price$7.58
Change+$0.33 (+4.55%)
Volume$309.56K
Capitalization1.46B
SFOSF vs TCNNF Comparison Chart in %
Loading...
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SFOSF vs. TCNNF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SFOSF is a Hold and TCNNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (SFOSF: $2.85 vs. TCNNF: $7.58)
Brand notoriety: SFOSF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SFOSF: 13% vs. TCNNF: 40%
Market capitalization -- SFOSF: $10.66B vs. TCNNF: $1.46B
SFOSF [@Pharmaceuticals: Generic] is valued at $10.66B. TCNNF’s [@Pharmaceuticals: Generic] market capitalization is $1.46B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SFOSF’s FA Score shows that 1 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • SFOSF’s FA Score: 1 green, 4 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, SFOSF is a better buy in the long-term than TCNNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SFOSF’s TA Score shows that 3 TA indicator(s) are bullish while TCNNF’s TA Score has 4 bullish TA indicator(s).

  • SFOSF’s TA Score: 3 bullish, 2 bearish.
  • TCNNF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SFOSF is a better buy in the short-term than TCNNF.

Price Growth

SFOSF (@Pharmaceuticals: Generic) experienced а +23.91% price change this week, while TCNNF (@Pharmaceuticals: Generic) price change was -13.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SFOSF($10.7B) has a higher market cap than TCNNF($1.46B). SFOSF YTD gains are higher at: 58.307 vs. TCNNF (46.233). SFOSF has higher annual earnings (EBITDA): 5.91B vs. TCNNF (280M). SFOSF has more cash in the bank: 16.1B vs. TCNNF (393M). TCNNF has less debt than SFOSF: TCNNF (824M) vs SFOSF (36.2B). SFOSF has higher revenues than TCNNF: SFOSF (40.3B) vs TCNNF (1.19B).
SFOSFTCNNFSFOSF / TCNNF
Capitalization10.7B1.46B732%
EBITDA5.91B280M2,111%
Gain YTD58.30746.233126%
P/E Ratio16.69N/A-
Revenue40.3B1.19B3,401%
Total Cash16.1B393M4,097%
Total Debt36.2B824M4,393%
FUNDAMENTALS RATINGS
SFOSF vs TCNNF: Fundamental Ratings
SFOSF
TCNNF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8295
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
5116
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SFOSF's Valuation (25) in the null industry is somewhat better than the same rating for TCNNF (83). This means that SFOSF’s stock grew somewhat faster than TCNNF’s over the last 12 months.

SFOSF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that SFOSF’s stock grew similarly to TCNNF’s over the last 12 months.

SFOSF's SMR Rating (82) in the null industry is in the same range as TCNNF (95). This means that SFOSF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (36) in the null industry is in the same range as SFOSF (38). This means that TCNNF’s stock grew similarly to SFOSF’s over the last 12 months.

TCNNF's P/E Growth Rating (16) in the null industry is somewhat better than the same rating for SFOSF (51). This means that TCNNF’s stock grew somewhat faster than SFOSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SFOSFTCNNF
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
45%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
53%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
51%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
45%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
57%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINJX44.620.24
+0.54%
MFS International Intrinsic Value R6
WEMAX9.770.04
+0.41%
Allspring Emerging Growth A
IIIAX13.050.05
+0.38%
Voya International Index Port A
PAGYX22.220.01
+0.05%
Putnam Dynamic Asset Allocation Gr Y
ATGYX47.94-0.01
-0.02%
Cantor Fitzgerald Equity Opp Inst

SFOSF and

Correlation & Price change

A.I.dvisor tells us that SFOSF and BIOVF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SFOSF and BIOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SFOSF
1D Price
Change %
SFOSF100%
N/A
BIOVF - SFOSF
21%
Poorly correlated
N/A
TKPHF - SFOSF
7%
Poorly correlated
+11.86%
PHCUF - SFOSF
7%
Poorly correlated
N/A
SGIOF - SFOSF
5%
Poorly correlated
N/A
TCNNF - SFOSF
3%
Poorly correlated
+4.55%
More

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+4.55%
GTBIF - TCNNF
82%
Closely correlated
+4.55%
CURLF - TCNNF
78%
Closely correlated
+1.79%
VRNOF - TCNNF
76%
Closely correlated
+5.51%
CRLBF - TCNNF
76%
Closely correlated
+5.26%
TSNDF - TCNNF
75%
Closely correlated
+13.08%
More